Thursday, November 05, 2020

The Profits of the COVID-19 Vaccine

 The future market for Covid-19 vaccines could be worth more than $10bn (£7.6bn) in annual revenues for pharmaceutical companies, according to industry experts, even though some drug-makers have pledged to provide their vaccines on a not-for-profit basis during this pandemic.

Matthew Harrison, an analyst at Morgan Stanley, estimates that even if only those who receive an annual flu jab take a Covid-19 shot, this would generate $10bn a year in revenues for the pharmaceutical industry in the US, Europe and other developed countries.

Evan Seigerman, an analyst at Credit Suisse, said the US market alone could be worth $10bn.

No comments: